AD

(5R,8S,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1-propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17(4H)-diol(CAS: 84371-64-2)

(5R,8S,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1-propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17(4H)-diol
CAS Number

Related Products

Other Suppliers for (5R,8S,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1-propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17(4H)-diol

Basic Information

Molecular Formula
C31H41NO4
Molecular Weight
30.07 g/mol

Physical Properties

Boiling Point
664.475 °C at 760 mmHg
Density
1.24
Flash Point
355.662 °C

Chemical Identifiers

SMILES
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC5(C[C@@]4(CC[C@@H]23)O)OCCO5)c6ccc(cc6)N(C)C)C)O
InChIKey
RIJGHAHZKTWZNK-NJPSTFMDSA-N

Database References

MDL Number
MFCD09952486

FAQ

This compound must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for classification and labeling. For European Union (EU) manufacturers, distributors, and importers, REACH regulations also apply, requiring registration and authorization if it falls under the scope. In the United States, the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) may require specific handling and reporting procedures, especially if used in pharmaceutical, cosmetic, or industrial applications.
For synthesis, alternatives such as (5E,8S,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1-propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17(4H)-diol or related analogs can be considered. Additionally, isomers like (5Z,8S,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1-propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17(4H)-diol may serve as viable substitutes.
Research trends indicate an increasing interest in this compound for its potential in pharmaceuticals and cosmetics. Market demand is rising due to its unique properties. Emerging research focuses on its biological activity and its application in drug delivery systems. Economic trends show a steady growth, driven by growing demand and technological advancements.
Waste containing this compound should be collected in appropriate containers and stored under controlled conditions to prevent contamination. For disposal, it is recommended to use professional waste disposal services that comply with local regulations. Incineration is a common method, provided that it is conducted in an environmentally friendly manner. Proper environmental protection measures, such as proper venting and scrubbing systems, should be in place to minimize emissions and protect the environment.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

greenleaf@greenleafpharm.com